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Abstract 
Purpose: To evaluate the incidence and progression of small refractile vacuoles (glistenings) in 
a consecutive series of patients implanted with the Surgidev B20/20 polymethylmethacrylate 
(PMMA) intraocular lens (IOL). 
Design: Observational case series. A 4-year prospective study of the progression of glistenings 
in patients implanted with the Surgidev B20/20 PMMA IOLs. 
Methods: In a clinical practice, a prospective study of glistenings was performed in a 
consecutive series of 51 patients (73 eyes) that received the Surgidev B20/20 IOL. Onset, size 
and location of IOL glistenings, best-corrected visual acuity, and associated ocular pathology 
were also noted. 
Results: With mean follow-up of 98 ± 27 months (range 48-176 months), 65 of 73 (89%) eyes 
had IOL glistenings. Glistenings increased in frequency and size with increasing follow-up 
(P=O.OOl). 
Conclusions: Glistenings may occur in PMMA IOLs with long-term follow-up and they are 
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We report observations of refractive opacities (glistenings) in a prospective consecutive 
case series of eyes that received the Surgidev B20/20 (Surgidev Corporations, Goleta, CA) 
polymethylmethacrylate (PMMA) intraocular lens (lOL). 
MATERIALS AND METHODS 
This is an observational case series of a 4-year prospective study of the progression of 
glistenings in patients implanted with the Surgidev B20/20 PMMA IOL. After glistenings were 
first noted in patients with Surgidev B20/20 IOLs in 1996, all patients with Surgidev B20/20 
lenses in one practice were followed prospectively for at least four years. Eyes with the 
Surgidev B20/20 IOL were graded a zero (0) if no glistenings were noted, 1 + when the 
glistenings were rare (less than 10), 2+ when they were moderate (10 to 50), and 3+ when they 
were profuse (>50) (Figure 1). The time from surgery at which the grading change was first 
noted, as well as the best-corrected visual acuity and any associated pathology, were also 
recorded. 
RESULTS 
A total of 51 patients with 73 Surgidev B20/20 IOLs were evaluated (Table). The 
c C follow-up varied between 48 and 176 months with an average of 98 months. As of June 2000, 
~ 
~ > 65 of 73 (89%) eyes with the Surgidev B20/20 IOL had glistenings. No glistenings were seen 
C 
r-t-5" sooner than three years postoperatively and all IOLs with over seven years of follow-up showed 
I-t 
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between best-corrected visual acuity and severity of glistenings (20122.7 ± 4.2 for 2 and 3+ 
glistenings versus 20/21.5 ± 3.3 for 0 and 1 + glistenings; P = 0.25). 
Clearly, there was evidence of progression with time with a mean glistening score of 1.70 
± .54 for those followed longer than the mean follow-up time (98 months) versus 1.20 ± .72 for 
those followed less (P = 0.001). Twelve IOLs showed progression during follow-up while four 
regressed and the rest remained unchanged. No correlation was found with diabetes mellitus. 
DISCUSSION 
This present series shows that changes that appear similar to AcrySof (Alcon, Fort 
Worth, TX) IOL glistenings can occur in PMMA IOLs with both progression over time and an 
incidence of 89% with an average of over eight years' follow-up. They first appear in the 
superficial layer of the IOL (equally posterior and anterior), then become diffuse through the 
optic. 
Exactly what is happening here is not known; however, it probably represents water 
vacuoles which are the probable cause of AcrySof IOL glistenings. 1 Molecular pore size large 
enough to allow water into the optic would result in visible refractive spherules if sufficiently 
large. This can be in small sizes that appear as a slight mist or as large as over 30 microns in 
diameter, which is very visible as distinct white opacities.2 They were not associated with 
diabetes mellitus. 
While we have shown that these are progressive over time in this particular PMMA IOL, 
we did not document any clinical impact. There have been studies suggesting a small but 
significant loss of contrast sensitivity3 or minor visual acuity change4 due to glistenings in 
AcrySof IOLs. 
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Alcon MC-50 BM and MC-60 BM PMMA IOLs have been clear to date with similar 
follow-up. We have rarely seen this in other PMMA IOLs. Wilson and Brubaker5 showed 
Perspex-CQ (lathe cut) PMMA IOLs to be 5+ times denser than mold injected lenses (our study 
lens). They also noted some glistenings in mold injected IOLs. Careful scrutiny by others will 
C undoubtedly show PMMA glistenings are not uncommon. 
C 
~ We do not feel our findings will result in significant visual symptoms; however, 
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Figure Legend: A Surgidev B20/20 IOL with moderate (2+) glistenings present. Photo at 16 
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Table: IOL glistenings in 51 patients (73 eyes) followed for more than 48 months after 
implantation of the Surgidev B20/20 intraocular lens. 
Grade Number of IOLs as Followed Followed Eyes of patients Eyes of patients who 
glistenings last seen for at least less than 98 with diabetes do not have diabetes 
Noted 98 months* months* mellitus mellitus 
0 0 8 0 8 3 5 
1+ <10 30 9 21 7 23 
2+ 10-50 34 17 17 12 22 
3+ > 50 1 1 0 1 0 
* t = 3.42, P = 0.001 
